CoChat
Sign Up
Cited by 94

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Rapamycin Suppresses Self-Renewal and Vasculogenic Potential of Stem Cells Isolated from Infantile Hemangioma

Greenberger, Shoshana, Yuan, Siming, Walsh, Logan A., Boscolo, Elisa, Kang, Kyu-Tae, Matthews, Benjamin, Mulliken, John B., Bischoff, Joyce·2011·Journal of Investigative Dermatology
DOI 10.1038/jid.2011.300PMC PMC3213330
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/jid.2011.300

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 39

  1. Amir, 1986, Strawberry hemangioma in preterm infants, Pediatr Dermatol, 3, 331, 10.1111/j.1525-1470.1986.tb00535.x · DOI
  2. Bennett, 2001, Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation, Arch Dermatol, 137, 1208, 10.1001/archderm.137.9.1208 · DOI
  3. Boon, 1999, Complications of systemic corticosteroid therapy for problematic hemangioma, Plast Reconstr Surg, 104, 1616, 10.1097/00006534-199911000-00002 · DOI
  4. Boscolo, 2011, JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation, Arterioscler Thromb Vasc Biol, 31, 2181, 10.1161/ATVBAHA.111.232934 · DOI
  5. Boye, 2001, Clonality and altered behavior of endothelial cells from hemangiomas, J Clin Invest, 107, 745, 10.1172/JCI11432 · DOI
  6. Darlington, 1998, The role of C/EBP genes in adipocyte differentiation, J Biol Chem, 273, 30057, 10.1074/jbc.273.46.30057 · DOI
  7. De Azevedo, 1997, Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine, Eur J Biochem, 243, 518, 10.1111/j.1432-1033.1997.0518a.x · DOI
  8. Drolet, 1999, Hemangiomas in children, N Engl J Med, 341, 173, 10.1056/NEJM199907153410307 · DOI
  9. Dubrovska, 2009, The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations, Proc Natl Acad Sci USA, 106, 268, 10.1073/pnas.0810956106 · DOI
  10. Frieden, 2009, Propranolol for infantile hemangiomas: promise, peril, pathogenesis, Pediatr Dermatol, 26, 642, 10.1111/j.1525-1470.2009.00977.x · DOI
  11. Geerts, 2008, Rapamycin prevents mesenteric neo-angiogenesis and reduces splanchnic blood flow in portal hypertensive mice, Hepatol Res, 38, 1130, 10.1111/j.1872-034X.2008.00369.x · DOI
  12. Greenberger, 2010, Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells, N Engl J Med, 362, 1005, 10.1056/NEJMoa0903036 · DOI
  13. Groszer, 2001, Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo, Science, 294, 2186, 10.1126/science.1065518 · DOI · Paper page
  14. Guba, 2002, Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor, Nat Med, 8, 128, 10.1038/nm0202-128 · DOI
  15. Haggstrom, 2006, Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development, Pediatrics, 117, 698, 10.1542/peds.2005-1092 · DOI
  16. Hall, 1990, Review: assessment of cell proliferation in histological material, J Clin Pathol, 43, 184, 10.1136/jcp.43.3.184 · DOI
  17. Hara, 1997, Regulation of eIF-4E BP1 phosphorylation by mTOR, J Biol Chem, 272, 26457, 10.1074/jbc.272.42.26457 · DOI
  18. Hill, 2009, PTEN, stem cells, and cancer stem cells, J Biol Chem, 284, 11755, 10.1074/jbc.R800071200 · DOI
  19. Hirschi, 1998, PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate, J Cell Biol, 141, 805, 10.1083/jcb.141.3.805 · DOI
  20. Ingram, 2004, Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood, Blood, 104, 2752, 10.1182/blood-2004-04-1396 · DOI
  21. Inoue-Narita, 2008, Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis, Cancer Res, 68, 5760, 10.1158/0008-5472.CAN-08-0889 · DOI
  22. Khan, 2008, Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice, J Clin Invest, 118, 2592
  23. Khan, 2006, Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin, Blood, 108, 915, 10.1182/blood-2006-03-006478 · DOI
  24. Kharas, 2010, Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice, Blood, 115, 1406, 10.1182/blood-2009-06-229443 · DOI
  25. Leaute-Labreze, 2008, Propranolol for severe hemangiomas of infancy, N Engl J Med, 358, 2649, 10.1056/NEJMc0708819 · DOI
  26. Li, 1996, SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis, Circ Res, 78, 188, 10.1161/01.RES.78.2.188 · DOI
  27. Loveless, 2009, Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model, Mol Imaging, 8, 187, 10.2310/7290.2009.00018 · DOI
  28. Meijer, 1997, Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5, Eur J Biochem, 243, 527, 10.1111/j.1432-1033.1997.t01-2-00527.x · DOI · Paper page
  29. Melero-Martin, 2008, Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells, Circ Res, 103, 194, 10.1161/CIRCRESAHA.108.178590 · DOI
  30. Melero-Martin, 2007, In vivo vasculogenic potential of human blood-derived endothelial progenitor cells, Blood, 109, 4761, 10.1182/blood-2006-12-062471 · DOI
  31. Olive, 2009, Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer, Science, 324, 1457, 10.1126/science.1171362 · DOI · Paper page
  32. Phung, 2007, Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression, Cancer Res, 67, 5070, 10.1158/0008-5472.CAN-06-3341 · DOI
  33. Prelich, 1987, Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein, Nature, 326, 517, 10.1038/326517a0 · DOI
  34. Siegfried, 2008, More on propranolol for hemangiomas of infancy, N Engl J Med, 359, 2846, 10.1056/NEJMc086443 · DOI
  35. Sindhi, 2005, Replacing calcineurin inhibitors with mTOR inhibitors in children, Pediatr Transplant, 9, 391, 10.1111/j.1399-3046.2005.00360.x · DOI
  36. Wu, 2008, Simultaneous occurrence of infantile hemangioma and congenital melanocytic nevus: Coincidence or real association?, J Am Acad Dermatol, 58, S16, 10.1016/j.jaad.2006.04.085 · DOI
  37. Yilmaz, 2006, Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells, Nature, 441, 475, 10.1038/nature04703 · DOI · Paper page
  38. Zhang, 2009, Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway, PLoS ONE, 4, e6189, 10.1371/journal.pone.0006189 · DOI
  39. Zhou, 2009, mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells, Proc Natl Acad Sci USA, 106, 7840, 10.1073/pnas.0901854106 · DOI

Cited by

Sorted by citations

See all 94

Metadata

Authors
Greenberger, S., Yuan, S., Walsh, L. A., Boscolo, E., Kang, K.-T., Matthews, B., Mulliken, J. B., & Bischoff, J.
Venue
Journal of Investigative Dermatology
Publisher
Elsevier BV
Published
2011-12
Volume
131
Issue
12
Pages
2467-2476
ISSN
0022-202X
DOI
10.1038/jid.2011.300
PMC
PMC3213330
Cited by
94
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review